Results for tag: "Rotigotine"

Rotigotine is a centrally-acting dopamine agonist used to treat Parkinson's disease and restless legs syndrome. It is a non-ergoline dopamine agonist, meaning it does not contain the ergot alkaloid found in some other dopamine agonists. Rotigotine is available in the form of a transdermal patch, which is applied to the skin and delivers a continuous dose of the drug over a 24-hour period. The patch is designed to provide a steady level of the drug in the body, which helps to reduce the symptoms of Parkinson's disease and restless legs syndrome. Rotigotine is a relatively new drug in the Central Nervous System (CNS) drugs market, but it has been gaining popularity due to its effectiveness in treating Parkinson's disease and restless legs syndrome. It is also seen as a safer alternative to other dopamine agonists, as it does not contain the ergot alkaloid found in some other dopamine agonists. Companies in the Rotigotine market include Novartis, UCB, and Teva Pharmaceuticals. Show Less Read more